Louis‐David Cantin

Mitigating the Inhibition of Human Bile Salt Export Pump by Drugs: Opportunities Provided by Physicochemical Property Modulation, In Silico Modeling, and Structural Modification

Daniel J. Warner, Hongming Chen, Louis‐David Cantin et al. · Drug Metabolism and Disposition · 2012 · 84 citations · Full text

Design, Synthesis, and Biological Evaluation of Monopyrrolinone-Based HIV-1 Protease Inhibitors

Amos B. Smith, Louis‐David Cantin, Alexander Pasternak et al. · Journal of Medicinal Chemistry · 2003 · 61 citations · Full text

Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s

Valérie Campágna‐Slater, Joshua Pottel, Éric Therrien et al. · Journal of Chemical Information and Modeling · 2012 · 57 citations

Computational Tool, Chemical Biology, Metabolic Model +20

Virtual Screening and Computational Optimization for the Discovery of Covalent Prolyl Oligopeptidase Inhibitors with Activity in Human Cells

Stéphane De Cesco, Sébastien Deslandes, Éric Therrien et al. · Journal of Medicinal Chemistry · 2012 · 55 citations · Full text

Covalent Inhibitors, Drug Target, Peptide Science +19

The synthesis of enantiomerically pure, symmetrically substituted cyclopropane phosphonic acids — A constrained analog of the GABA antagonist phaclophen

Stephen Hanessian, Louis‐David Cantin, Stéphan Roy et al. · Tetrahedron Letters · 1997 · 52 citations

Constrained Analog, Bioorganic Chemistry, Gaba Antagonist Phaclophen +8